Horn & Co. advised ART Medical Ltd. on the deal. Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here